. Some patients with Albright's hereditary osteodystrophy and many of those with normal or tall body builds have radiological hyperparathyroidism. A classification of these unusual and complicated disorders has been given by Nusynowitz et al. (1976). We describe a boy with an unusual phenotype who showed many features of resistance to PTH and yet remained normocalcaemic for some years and who presented with the bony consequences of prolonged exposure to high levels of PTH.
Hypoparathyroidism and states of resistance to parathyroid hormone (PTH) are among the causes of persistent hypocalcaemia in childhood. Most such patients have the round facies, short stature, and short metacarpals which constitute the phenotype of Albright's hereditary osteodystrophy. A few have a normal somatotype or even unusual tallness, as in the patient described by Costello and Dent (1963) . Some patients with Albright's hereditary osteodystrophy and many of those with normal or tall body builds have radiological hyperparathyroidism. A classification of these unusual and complicated disorders has been given by Nusynowitz et al. (1976) . We describe a boy with an unusual phenotype who showed many features of resistance to PTH and yet remained normocalcaemic for some years and who presented with the bony consequences of prolonged exposure to high levels of PTH.
Case report A boy weighing 2 8 kg at birth, and with no significant family history, presented with failure to thrive and hypocalcaemia at age 10 weeks. The biochemical abnormalities persisted for a few months. Thereafter he was well apart from a profound tColegio Major Fonseca, Plaza Fonseca, Salamanca, Spain. sensorineural deafness diagnosed at the age of one year. At 4k years he was referred to the late Professor C. E. Dent because of osteosclerosis.
On examination he was of normal intelligence and stature. He was deaf and had an unusual round face ( Fig. 1 ) with some proptosis. Plasma calcium was 2 25 mmol/l (9 mg/100 ml), magnesium 0-71 mmol/l (1I7 mg/100 ml), phosphorus 1 46 mmol/l (4 5 mg/100 ml), and alkaline phosphatase 24 KA units. Plasma urea and electrolytes were normal and haemoglobin was 11 * 2 g/dl. Plasma 25-hydroxyvitamin D (25-OHD) was 23 nmol/l (9 ng/ml) (normal Fig. 1 (Fig. 2) and erosions at the wrist, slight distortion of the right femoral head, and metacarpals of normal length.
Response to injected bovine PTH (bPTH) is described below (Table and Fig. 4 ). Because of progression of the lesion in the right femoral head and the similar appearance on the left we felt obliged to attempt to reduce the output of the parathyroid glands. He was first treated with vitamin D (2 mg/day for 5 days and 1 mg/day for another 5 days) in an attempt to suppress the parathyroids. This gave rise to sustained hypercalcaemia while plasma phosphorus fell. At this stage a second bPTH injection was given (see Table) .
As medical suppression of the parathyroids had failed, a total parathyroidectomy (Mr G (Costello and Dent 1963; Cohen and Vince, 1969; Frame and Parfitt, 1973) . Many of these patients have a completely normal phenotype. Our patient is of interest from several points of view. Firstly, the unusual facies and sensorineural deafness are anomalies not hitherto associated with resistance to PTH. Secondly, the finding of radiological osteosclerosis distinguishes him from other children with resistance to PTH, although hyperparathyroidism with a high plasma phosphate is often stated to be the cause of osteosclerosis in uraemia. Thirdly, his ability to maintain a normal plasma calcium until parathyroidectomy, and the development of hypocalcaemia 6 days after operation show that resistance to PTH, at least at the skeletal level, was far from complete. On the other hand the normocalcaemia in the face of very high levels of serum immunoreactive PTH and in the presence of hyperparathyroid skeletal changes indicates some degree of resistance to the calciumraising action of the hormone.
Lastly, the responses to vitamin D and later to parathyroidectomy require explanation. Treatment with nontoxic quantities of vitamin D produced hypercalcaemia. Plasma calcium remained high for 4 months until parathyroidectomy, despite the fact that his 25-OHD levels had returned to normal within one month of a 10-day course of vitamin D. At the same time vitamin D treatment lead to a sustained fall in plasma phosphate presumably by restoring some degree of renal tubular sensitivity to endogenous PTH. Restoration of the calcium-raising and phosphaturic capabilities of PTH by vitamin D treatment in pseudohypoparathyroidism has been described (Stogmann and Fischer, 1975 
